QRG Capital Management Inc. Has $290,000 Holdings in Bath & Body Works, Inc. $BBWI

QRG Capital Management Inc. lowered its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 81.4% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 11,244 shares of the company’s stock after selling 49,053 shares during the period. QRG Capital Management Inc.’s holdings in Bath & Body Works were worth $290,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in BBWI. Summit Investment Advisors Inc. bought a new stake in Bath & Body Works during the first quarter worth $1,292,000. Intech Investment Management LLC grew its stake in shares of Bath & Body Works by 53.5% in the 2nd quarter. Intech Investment Management LLC now owns 58,460 shares of the company’s stock worth $1,751,000 after acquiring an additional 20,381 shares in the last quarter. JPMorgan Chase & Co. grew its stake in shares of Bath & Body Works by 11.5% in the 2nd quarter. JPMorgan Chase & Co. now owns 7,080,106 shares of the company’s stock worth $212,120,000 after acquiring an additional 733,000 shares in the last quarter. GMT Capital Corp raised its holdings in shares of Bath & Body Works by 8.8% in the second quarter. GMT Capital Corp now owns 4,067,000 shares of the company’s stock valued at $121,847,000 after purchasing an additional 329,300 shares during the last quarter. Finally, Mitsubishi UFJ Trust & Banking Corp lifted its position in shares of Bath & Body Works by 126.3% during the second quarter. Mitsubishi UFJ Trust & Banking Corp now owns 271,727 shares of the company’s stock valued at $8,141,000 after purchasing an additional 151,668 shares in the last quarter. 95.14% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on BBWI shares. The Goldman Sachs Group downgraded shares of Bath & Body Works from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $39.00 to $17.00 in a research report on Thursday, November 20th. Jefferies Financial Group assumed coverage on Bath & Body Works in a research note on Wednesday, January 14th. They issued a “hold” rating and a $24.00 target price on the stock. Bank of America reduced their target price on Bath & Body Works from $40.00 to $32.00 and set a “buy” rating for the company in a report on Thursday, November 20th. Wells Fargo & Company dropped their price target on Bath & Body Works from $33.00 to $25.00 and set an “overweight” rating on the stock in a report on Friday, November 21st. Finally, Raymond James Financial reissued a “market perform” rating on shares of Bath & Body Works in a research report on Wednesday, November 12th. Five equities research analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $23.53.

Key Headlines Impacting Bath & Body Works

Here are the key news stories impacting Bath & Body Works this week:

• Positive Sentiment: Zacks upgraded BBWI from “strong sell” to “hold,” which could temper selling pressure by some investors. Zacks Upgrade
• Neutral Sentiment: Brokerage consensus remains a “hold,” indicating analysts are not broadly bullish despite volatility. Consensus Hold
• Negative Sentiment: Multiple national law firms have filed or announced investigations and are soliciting lead plaintiffs in a securities‑class action alleging material misstatements/omissions covering June 4, 2024–Nov. 19, 2025 — raising the prospect of litigation costs, management distraction and reputational damage. Schall Law Firm Notice
• Negative Sentiment: Bleichmar Fonti & Auld and other firms cite a significant prior stock drop (reports reference a ~24% plunge) tied to the alleged disclosures, and are urging investors to contact counsel — this amplifies near‑term selling and uncertainty. BFA Fraud Alert
• Negative Sentiment: Additional plaintiff firms (Kessler Topaz, Rosen, Levi & Korsinsky, Bragar, Pomerantz, Faruqi, Kaplan Fox, and others) have issued alerts and deadline reminders for lead‑plaintiff motions (mid‑March deadlines), signaling broad, coordinated litigation activity. Kessler Topaz Alert

Insider Buying and Selling at Bath & Body Works

In other Bath & Body Works news, Director Steven E. Voskuil bought 20,000 shares of the business’s stock in a transaction on Friday, November 21st. The stock was purchased at an average price of $15.04 per share, for a total transaction of $300,800.00. Following the completion of the transaction, the director directly owned 33,925 shares of the company’s stock, valued at $510,232. This trade represents a 143.63% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Lucy Brady bought 3,470 shares of Bath & Body Works stock in a transaction dated Friday, November 21st. The stock was acquired at an average price of $14.40 per share, with a total value of $49,968.00. Following the purchase, the director directly owned 17,482 shares of the company’s stock, valued at approximately $251,740.80. This represents a 24.76% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired 33,513 shares of company stock valued at $500,442 in the last three months. 0.26% of the stock is owned by company insiders.

Bath & Body Works Stock Down 1.8%

Shares of BBWI stock opened at $22.17 on Friday. The firm has a market cap of $4.54 billion, a P/E ratio of 6.82, a PEG ratio of 0.81 and a beta of 1.51. The company has a 50 day moving average of $20.14 and a 200-day moving average of $25.11. Bath & Body Works, Inc. has a 12-month low of $14.27 and a 12-month high of $41.87.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Thursday, November 20th. The company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.40 by ($0.05). Bath & Body Works had a net margin of 9.50% and a negative return on equity of 47.35%. The firm had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter in the previous year, the company posted $0.49 EPS. Bath & Body Works’s revenue for the quarter was down 1.0% on a year-over-year basis. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS and its Q4 2025 guidance at 1.700- EPS. As a group, equities analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 5th. Investors of record on Friday, November 21st were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 3.6%. The ex-dividend date was Friday, November 21st. Bath & Body Works’s payout ratio is currently 24.62%.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.